Private · Company · Aksjeselskap
Vaxxinova Norway AS
995 153 637 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Bergen
↳ Brreg · companies
MoneyNOK
Revenue
kr 17.7M
Operating result
−kr 35.5M
Net result
−kr 24.6M
Total assets
kr 78.7M
Equity
kr 893k
FY2025 kr 17.7M vs FY2024 kr 14.4M · +23% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
- Revenue
- Net profit
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue | 12.7M | 14.4M | 17.7M |
| Net profit | — | — | -24.6M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY23FY24FY25TREND
Revenue13M14M18M
Operating result-25M-29M-36M
Net result——-25M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by DELOITTE AS.
BALANCEEquity kr 893k.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose